(IDYA) – Upgrades
-
Ideaya Biosciences upgraded to Buy, Shares jump on positive Interim Phase 2 data for Darovasertib and Crizotinib combination
-
Stifel Upgrades Ideaya Biosciences (IDYA) to Buy 'on Increased Conviction in the Darovasertib 1L MUM Opportunity'
-
-
Back to IDYA Stock Lookup